| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 04/21/1991 | CA2069342A1 Materials and methods for the treatment of foreign tissue |
| 04/21/1991 | CA2028086A1 Glycosyl-etoposide prodrugs, a process for the preparation thereof and the use thereof in combination with functionalized tumor-specific enzyme conjugates |
| 04/21/1991 | CA2028045A1 Infectious bronchitis virus vaccine |
| 04/21/1991 | CA2028024A1 Tumor-associated antigen |
| 04/19/1991 | WO1991005793A1 Production and use of human nm23 protein and antibodies therefor |
| 04/19/1991 | WO1991005569A1 Novel infectious bursal disease virus |
| 04/19/1991 | CA2067397A1 Infectious bursal disease virus |
| 04/18/1991 | WO1991005046A1 Granulocyte-colony stimulating factor receptors |
| 04/18/1991 | WO1991005038A1 Blood-brain barrier model |
| 04/18/1991 | WO1991004986A1 Oligopeptides/expression products of the aujeszky's disease virus, and recombinant polynucleotides coding therefor |
| 04/18/1991 | WO1991004755A1 Methods for reducing non-target retention of immunoconjugates and metabolites thereof |
| 04/18/1991 | WO1991004750A1 Method of treatment |
| 04/18/1991 | WO1991004749A1 Method of treating infectious bursal disease virus |
| 04/18/1991 | WO1991004748A1 INHIBITING TRANSFORMING GROWTH FACTOR β TO PREVENT ACCUMULATION OF EXTRACELLULAR MATRIX |
| 04/18/1991 | WO1991004747A1 Protection vaccine against swine hemophilosis |
| 04/18/1991 | WO1991004727A1 Device for oral administration of an active principle for preventive treatment of caries in babies |
| 04/18/1991 | WO1991004316A3 Ciliary neurotrophic factor |
| 04/18/1991 | WO1991002805A3 Recombinant retroviruses delivering vector constructs to target cells |
| 04/18/1991 | WO1990015076A3 MONOCLONAL ANTIBODIES AGAINST LEUKOCYTE ADHESION RECEPTOR β-CHAIN, METHODS OF PRODUCING THESE ANTIBODIES AND USE THEREFORE |
| 04/18/1991 | WO1990015066A3 Nucleotidic sequences resulting from the retrovirus gemone of the hiv-1, hiv-2, and siv type, and their applications, in particular for the amplification of the genomes of said retroviruses and for the in vitro diagnosis of infections caused by these viruses |
| 04/18/1991 | DE3934366A1 Vakzine zum schutz vor hiv-virusinfektionen, verfahren zu ihrer herstellung und ihre verwendung als diagnostikum und immuntherapeutikum Vaccine to protect against hiv virus infections, methods for their production and their use as diagnostic and immunotherapeutic |
| 04/18/1991 | DE3933850A1 Zytolyse-inhibitor (zli), eine diese blutplasmaprotein kodierende dna-sequenz, sowie ein plasmid, ein wirtsorganismus und ein verfahren zur gewinnung dieses proteins Cytolysis inhibitor (ZLI), these a blood plasma protein encoding DNA sequence, and a plasmid, a host organism and a method for obtaining this protein |
| 04/17/1991 | WO1991005860A1 Non-infectious hiv-1 particles and uses therefor |
| 04/17/1991 | EP0423077A1 Tripeptide compounds and their pharmaceutical use as immunomodulators |
| 04/17/1991 | EP0422699A2 Methods for binding a compound on bibulous material |
| 04/17/1991 | EP0422186A1 Methods for controlling human endothelial cell proliferation and effector functions using oncostatin m |
| 04/17/1991 | EP0422115A1 Identification of human t-lymphocyte epitopes in pathogens for vaccine development |
| 04/17/1991 | CA2067778A1 Non-infectious hiv-1 particles and uses therefor |
| 04/16/1991 | US5008198 Hybridoma cell line producing monoclonal antibodies binding to antigens isolated from Plasmodium falciparum |
| 04/16/1991 | US5008184 Kit or system for detecting SIMA and/or LIMA antigens in physiological fluid |
| 04/16/1991 | US5008116 Immobilized antigen |
| 04/16/1991 | CA1283066C Monoclonal antibody specific to neutrophils |
| 04/16/1991 | CA1283045C Therapeutic and diagnostic methods using soluble t cell surface molecules |
| 04/16/1991 | CA1283044C Concentrating immunochemical test strip |
| 04/13/1991 | WO1991005801A1 Dopamine releasing protein |
| 04/13/1991 | CA2065442A1 Dopamine releasing protein |
| 04/13/1991 | CA2027455A1 Hiv related peptides |
| 04/11/1991 | WO1991005806A1 Interfacial condensation of bioactive compounds and the site-specific compounds and conjugates thereof |
| 04/11/1991 | DE3925748A1 New recombinant deoxyribonucleic acid - from foot=and=mouth disease virus, for prodn. of attenuated virus particles, useful in vaccines |
| 04/11/1991 | CA2067210A1 Interfacial condensation of bioactive compounds and the site-specific compounds and conjugates thereof |
| 04/11/1991 | CA2025231A1 Cancer marker and monoclonal antibodies specific therefor |
| 04/10/1991 | EP0421949A1 Chemically modified allergens and process for the preparation thereof |
| 04/10/1991 | EP0421876A1 Use of active agents in the preparation of a drug for the treatment of lymphomes or related diseases |
| 04/10/1991 | EP0421863A1 Therapeutic device for oral administration of a medicament to animals and process for production |
| 04/10/1991 | EP0421635A1 Chimaeric hepadnavirus core antigen proteins |
| 04/10/1991 | EP0421626A1 Vaccine for aids and hepatitis B |
| 04/10/1991 | EP0421382A1 Monoclonal antibody to exotoxin A of pseudomonas aeruginosa |
| 04/10/1991 | EP0421380A1 Tumor-lysing cell inducer, method for inducing tumor-lysing cell and device for inducing tumor-lysing cell |
| 04/10/1991 | EP0420942A1 Macrocyclic bifunctional chelants, complexes thereof and their antibody conjugates |
| 04/10/1991 | CN1050561A Recombinant adenovirus dna sequence, recombinant adenovirus expressing dna sequence and rhabdovirus vaccine including recombinant adenovirus |
| 04/09/1991 | US5006652 Intermediates for antibody-vinca drug conjugates |
| 04/09/1991 | US5006515 Immunology disorders, antitumor agent |
| 04/09/1991 | US5006472 Enzymatic purification process |
| 04/09/1991 | US5006459 Immunoassays |
| 04/09/1991 | US5006341 Water in palm kernel oil emulsion, sporulated oocyst of coccidium, protective coating of cement or gypsum; useful in oral immunization of poultry |
| 04/09/1991 | US5006335 Live vaccine against mumps and process for obtaining thereof |
| 04/09/1991 | US5006334 Antigenic modification of polypeptides |
| 04/09/1991 | CA1282779C Polysaccharide ron substance, production of the same and use of the same |
| 04/09/1991 | CA1282721C Herpes simplex virus as a vector |
| 04/09/1991 | CA1282697C Preparation for prevention and treatment of gastrointestinal diseases of farm animals |
| 04/09/1991 | CA1282695C Methods and materials for treatment of rheumatoid arthritis |
| 04/07/1991 | WO1991005043A1 Cytolysis inhibitor proteins (cli) and dna sequences coding for said proteins |
| 04/07/1991 | CA2042605A1 Cytolysis inhibitor proteins (cli), dna sequences coding for said proteins, and plasmids, host organisms, and processes for obtaining said proteins |
| 04/07/1991 | CA2027077A1 Application of active substances for the preparation of a drug for the treatment of lymphomas or related diseases, the drugs thus obtained and a process for the therapeutic treatment of lymphomas |
| 04/07/1991 | CA2027022A1 Compounds useful for measuring low levels of sulfonylureas by immunoassay |
| 04/05/1991 | CA2026803A1 Monoclonal antibody to exotoxin a of pseudomonas aeruginosa |
| 04/04/1991 | WO1991004493A1 Hiv-related epitopes for diagnosis and immunoprotection |
| 04/04/1991 | WO1991004339A1 Assays and reagents for amyloid deposition |
| 04/04/1991 | WO1991004330A1 Human parvovirus b19 proteins and virus-like particles, their production and their use in diagnostic assays and vaccines |
| 04/04/1991 | WO1991004324A1 Ribozyme compositions and methods for use |
| 04/04/1991 | WO1991004272A1 Recombinant polypeptides and peptides, nucleic acids coding for the same and use of these polypeptides and peptides in the diagnostic of tuberculosis |
| 04/04/1991 | WO1991004055A1 Treatment of autoimmune disease |
| 04/04/1991 | WO1991004054A1 Treatment of ards |
| 04/04/1991 | WO1991004053A1 Pharmaceutical composition that makes cells expressing mhc class ii antigens targets for cytotoxic t-cells |
| 04/04/1991 | WO1991004051A1 Peptides including ctl epitopes of hiv proteins and use thereof |
| 04/04/1991 | WO1991004049A1 CONJUGATE VACCINE FOR GROUP B $i(STREPTOCOCCUS) |
| 04/04/1991 | WO1991004036A1 TREPONEMA HYODYSENTERIAE ANTIGENS HAVING A MOLECULAR WEIGHT OF 39kDa AND DNA ENCODING THEREFOR |
| 04/04/1991 | WO1991004030A1 Use of steroid hormones in compositions for inducing t cell lymphokine production |
| 04/04/1991 | WO1991000289A3 Targeted liposomes and methods for liposome-protein coupling |
| 04/04/1991 | DE3931839A1 Neue proteine und ihre herstellung New proteins and their production |
| 04/04/1991 | CA2383393A1 Conjugate vaccine for group b streptococcus |
| 04/04/1991 | CA2066716A1 Use of steroid hormones in compositions for inducing t cell lymphokine production |
| 04/04/1991 | CA2066647A1 Ribozyme compositions and methods for use |
| 04/03/1991 | EP0420785A2 Stable immunogen composition |
| 04/03/1991 | EP0420759A1 Method of preparation of an immunizing composition |
| 04/03/1991 | EP0420743A1 Vaccine protecting against porcine hemophilus |
| 04/03/1991 | EP0420459A2 Oral pharmaceutical composition for acid sensitive proteinaceous agents |
| 04/03/1991 | EP0420043A1 Antibodies against highly conservated amino acid sequences of immunogenic substances, process of preparation of these antibodies and their use as immunoessays |
| 04/03/1991 | EP0419997A1 Cloning of the gene which codes for the pilinic subunit FIM3 of Bordetella pertussis |
| 04/03/1991 | EP0419858A1 Dog-mouse heterohybridoma and gene fragment coding for constant region of canine immunoglobulins |
| 04/03/1991 | EP0419666A1 Promoter, plasmid containing the same, and recombinant avipoxvirus |
| 04/03/1991 | EP0419648A1 Nucleotidic sequences of actinomycetales, applications to the synthesis or detection of nucleic acids, products of expression of such sequences and application as immunogenic compositions |
| 04/03/1991 | EP0419576A1 Enterically transmitted non-a/non-b hepatitis viral agent |
| 04/03/1991 | EP0419532A1 A pharmaceutical preparation and a conjugate of a bactericide and an antibody directed against plaque forming or caries-inducing bacteria |
| 04/03/1991 | EP0242380B1 A process for preparing immunogenic complex |
| 04/03/1991 | CN1050373A Process for preparing optically active 2-aryl-alkanoic acid, in particular 2-aryl propionic |
| 04/02/1991 | USRE33565 Antibody for passive immunization |
| 04/02/1991 | US5004697 Cationized antibodies for delivery through the blood-brain barrier |
| 04/02/1991 | US5004694 Complement-dependent cytolytic anti-Trichomonas vaginalis monoclonal antibodies |
| 04/02/1991 | US5004693 For insertion into viral genome at restriction enzyme cleavage site |